Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-08-14 00:00:00 ET · period of report 2024-08-12 · accession 0000950170-24-097290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-14 | 2024-08-12 | WVE | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +16.1K | 16.1K | New | $0 |
| D | 2024-08-14 | 2024-08-12 | WVE | Rawcliffe Adrian | Dir | A - Grant | $0.00 | +32.2K | 32.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-08-12 | A | A | 16,115 | $0.00 | 16,115 | D | — | — | (F1) The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025. |
| 2 | Derivative | Share Option (right to buy) | 2024-08-12 | A | A | 32,230 | $0.00 | 32,230 | D | $5.37 · — to 2029-08-12 | 32,230 Ordinary Shares | (F2) The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025. |